Table 2.
Positive and negative cases of kidney dysfunction in each group
| Urine Biomarker | Normal (n=15) | ATN (n=29) | AR (n=41) | Control (n=15) | |
|---|---|---|---|---|---|
| κFLC (< 20 mg/L) | Positive | 0 (0%) | 28 (97%) | 39 (95%) | 1 (7%) |
| Negative | 15 (100%) | 1 (3%) | 2 (5%) | 14 (93%) | |
| λFLC (< 17 mg/L) | Positive | 0 (0%) | 17 (59%) | 25 (61%) | 0 (0%) |
| Negative | 15 (100%) | 12 (41%) | 16 (39%) | 15 (100%) | |
| (κ+λ) FLC (< 40 mg/L) | Positive | 0 (0%) | 26 (90%) | 36 (88%) | 0 (0%) |
| Negative | 15 (100%) | 3 (10%) | 5 (12%) | 15 (100%) | |
| MAB (< 40 mg/L) | Positive | 0 (0%) | 15 (52%) | 23 (56%) | 5 (33%) |
| Negative | 15 (100%) | 14 (48%) | 18 (44%) | 10 (67%) | |
| μ2-M (< 200 μg/L) | Positive | 0 (0%) | 24 (83%) | 34 (83%) | 0 (0%) |
| Negative | 15 (100%) | 5 (17%) | 7 (17%) | 15 (100%) | |
| RBP (< 0.56 mg/L) | Positive | 0 (0%) | 25 (86%) | 32 (78%) | 1 (7%) |
| Negative | 15 (100%) | 4 (14%) | 9 (22%) | 14 (93%) | |
| KIM-1 (< 2.15 μg/L) | Positive | 0 (0%) | 1 (3%) | 7 (17%) | 2 (13%) |
| Negative | 15 (100%) | 28 (97%) | 34 (83%) | 13 (87%) | |
| NGAL (< 5.3 μg/L) | Positive | 0 (0%) | 16 (55%) | 18 (44%) | 10 (67%) |
| Negative | 15 (100%) | 13 (45%) | 23 (56%) | 5 (33%) | |
Data are expressed as number (percentage)
The highest urine concentration in Normal group is used as the upper “normal limit” for each biomarker (left column)